PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 31 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $151,819 | -9.7% | 30,063 | -10.1% | 0.00% | – |
Q2 2023 | $168,123 | -39.0% | 33,424 | -25.4% | 0.00% | – |
Q1 2023 | $275,544 | -24.0% | 44,804 | +63.1% | 0.00% | – |
Q4 2022 | $362,710 | +312.2% | 27,478 | -7.5% | 0.00% | – |
Q3 2022 | $88,000 | -60.9% | 29,700 | -51.7% | 0.00% | – |
Q2 2022 | $225,000 | -38.2% | 61,531 | +4.6% | 0.00% | – |
Q1 2022 | $364,000 | +970.6% | 58,840 | +1310.4% | 0.00% | – |
Q4 2021 | $34,000 | +3300.0% | 4,172 | +7093.1% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 58 | -71.7% | 0.00% | – |
Q2 2021 | $2,000 | – | 205 | +93.4% | 0.00% | – |
Q1 2021 | $0 | – | 106 | +606.7% | 0.00% | – |
Q4 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 15 | -94.3% | 0.00% | – |
Q4 2019 | $1,000 | -50.0% | 265 | -54.4% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 581 | +388.2% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 119 | -21.2% | 0.00% | – |
Q1 2019 | $1,000 | – | 151 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |